ENTRY       D11868                      Drug
NAME        Efruxifermin (USAN)
FORMULA     C4090H6330N1126O1254S24
EXACT_MASS  92051.9464
MOL_WEIGHT  92108.375
SEQUENCE    MDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV
            DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA
            KGQPREPQVY TLPPSRDELT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD
            SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGKGG GGSGGGGSGG
            GGSHPIPDSS PLLQFGGQVR QRYLYTDDAQ QTEAHLEIRE DGTVGGAADQ SPESLLQLKA
            LKPGVIQILG VKTSRFLCQR PDGALYGSLH FDPEACSFRE RLLEDGYNVY QSEAHGLPLH
            LPGNKSPHRD PAPRGPARFL PLPGLPPAPP EPPGILAPQP PDVGSSDPLS MVGGSQGRSP
            SYES
            (Disulfide bridge: 7-7', 10-10', 42-102, 148-206, 318-336, 42'-102', 148'-206', 318'-336')
  TYPE      Peptide
EFFICACY    Fibroblast growth factor replacement
COMMENT     Treatment of nonalcoholic steatohepatitis (NASH)
TARGET      FGF21 [HSA:26291] [KO:K22429]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                FGF21
                 D11868  Efruxifermin (USAN)
DBLINKS     CAS: 2375240-92-7
///
